Trial intelligence / Profile preview

Docetaxel and Carboplatin Neoadjuvant Chemotherapy in Advanced Ovarian Cancer

NCT01462149Phase 2Completed

Sponsor
Asan Medical Center
Start
Oct 2011
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in ovarian cancer, sponsored by Asan Medical Center. Started Oct 2011; status: completed.

02

Drugs

docetaxel
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on NCT01462149.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01462149.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call